ambr® 250
ambr® 250 is a new bioreactor system for parallel fermentation or cell culture using 100-250mL single-use bioreactors controlled by an automated liquid handling platform.The new system, developed with two major industrial partners, builds on the original ambr® microscale technology developed by TAP Biosystems (now part of Sartorius Stedim Biotech).
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
Perfect tool for PD upstream
Process development, media optimization and perfusion
Perfect for the cell cuture development with minimal requirement of man power. Automation plays an important role with the ambr, it is perfect for the PD stage. It reduces your timelines significantly and gives you a room for testing for many parallel experiments.
Review Date: 8 Jun 2022 | Sartorius Group
The new gold standard for process development.
Microbial fermentation
Ambr250 HT, the new standard for the development lab for microbial or mamalian process development, characterization, strain or media/feed screen. Up to 24 vessels can each be dedicated to a specific set of parameters, enabling robust and significant decision making when performing DoE. Add the online analyzer platforms and free time for your lab scientist to switch from actually running the experiment to deeper analysis. The only question that you should ask at a job interview for an upstream position: "Will I get to work on an Ambr250?" If not, run away.
Review Date: 18 May 2020 | Sartorius Group
Ambr250 is inevitable for USP development. Intuitive programming, maximum flexibility.
Upstream process development
5 Years of USP development using the Ambr250 for microbial activities. Everyone in the UPS team is able to program and follow the fermentation regardless their initial level in computer sciences. Jumping from one experiment to another is only a matter of how good you are in planning your activities! The software is DoE friendly and allows you to complete your most bizarre design or up to 12 fermentations at a time with an investigation capability that definitely overtakes what literature says your strain can undergo.
Review Date: 12 Jun 2019 | Sartorius Group
ambr® 250 is a new bioreactor system for parallel fermentation or cell culture using 100-250mL single-use bioreactors controlled by an automated liquid handling platform.
The new system, developed with two major industrial partners, builds on the original ambr® microscale technology developed by TAP Biosystems (now part of Sartorius Stedim Biotech).
Brochures
ambr® 250 modular Single-Use Benchtop Bioreactor with Simplified Operation for Increased Productivity
This brochure provides technical information for the ambr® 250 modular, an innovative new high performance benchtop bioreactor system for parallel microbial or cell culture in 100 - 250 mL single-use vessels.
Integration of the Vi-CELL BLU Cell Viability Analyzer into the Sartorius Ambr 250 High Throughput
A Vi-CELL BLU cell viability analyzer integrated into a Sartorius Ambr® 250 High Throughput system leverages the strengths of both instruments and provides users with the advantages of automated cell culture handling and analysis. The combination of these technologies provides researchers and bioprocess engineers with many benefits, such as continuous monitoring and enhanced data analysis, while saving valuable time and resources. Automated cell culture analysis helps optimize workflows and could improve scalability. Explore the data from cultivations performed in a Sartorius Ambr® 250 High Throughput system which were sampled daily on an integrated Vi-CELL BLU analyzer to determine cell concentration and viability online. These results are compared with offline values.
Integrated Upstream Platform - From Cell Line to Manufacturing
Sartorius Stedim Biotech has developed the first fully integrated upstream platform. It connects a top-performing expression system with outstanding equipment and process control for the rapid development and scale-up of robust, high-titer commercial manufacturing processes. Find out more on the website: https://www.connect-upstream.com/
Sartorius partners with RoosterBio to advance cell and gene therapy manufacturing
The collaboration aims to advance the scale-up of hMSC manufacturing for regenerative medicine
Sartorius Stedim Biotech Supports Mainstream Adoption of Quality by Design
Unique technology portfolio enables design space characterization, effective translation to the large-scale and enhanced process analytics
Sartorius Stedim Biotech Launches Innovative ambr® 250 Modular Bioreactor System
New expandable benchtop workstation with unique single-use bioreactor design offers a simple approach to process development for fermentation and cell culture
New Paper on Automated, Single-use, High-Throughput Process Development at Merck
Presents data on how scientists at Merck are using the ambr® 250 system as a tool for rapid development of both cell culture bioprocesses and microbial fermentation
